Archives

Kevin Birtchnell

Kevin J. Birtchnell has over twenty-five years of international finance and accounting experience. Kevin has extensive industry knowledge of corporate and financial management, of public and private equity and debt financing transactions, of mergers and acquisitions and of business development, most notably within the high technology start-up businesses.

Kevin currently operates as an independent consultant and board member for numerous businesses. Kevin was a professor of accounting and finance, and the director of an educational initiative at Golden Gate University in San Francisco, CA. Additionally, Kevin was called upon to offer expert technical advice in various legal and governmental hearings.

Previously, Kevin was the Chief Financial Officer to both private and public companies including: Nanomix Corporation, Xenogen Corporation, DIVA Communications and Somatix Therapy Corporation. Kevin qualified as a Chartered Accountant with the Institute of Chartered Accountants in England & Wales and trained with Arthur Andersen & Co., in London and with PriceWaterhouseCoopers in San Jose, CA. Kevin is a graduate of London University, England.

Anthony Sartoris

Anthony Sartoris formerly President of Doc’s Drugs Ltd. Doc’s Drugs, a family-owned chain of 17 pharmacies serving communities in north central Illinois. Founded in November 1978 by Dave Sartoris, Doc’s Drugs annual revenue exceeded $62 million and filled over 1 million prescriptions yearly. Doc’s Drugs focused on high level patient care that goes beyond just filling a prescription. He was the co-founder of the Community Pharmacy Prescription Network (CPRxN) a growing network of 735 independent pharmacies formed to service the needs of large employers in the direct-to-employer contracting of prescription drug benefits initiated by Caterpillar Incorporated in 2010. Mr. Sartoris has a Bachelor of Arts in Economics and Business from Eureka College and a Master of Business Administration from Lewis University.

Rinku A. Patel, PharmD

Rinku A. Patel, PharmD, is a registered pharmacist and an entrepreneur dedicated to simplifying the pharmacy care experience for patients using specialty medications. Dr. Patel believes in the fundamental principal of providing patients with the choice to select their pharmacy and their pharmacist for their medications and pharmaceutical care needs. The industry-imposed use of poly-pharmacy on patients ultimately results in poor medication adherence and sub-optimal health outcomes, as a result of increased complexity and disorganized care coordination. The pharmacy and health care industry stakeholders must accept and realize their responsibility to patients in reducing their barriers to access and giving them the choice of One Pharmacy Home.TM

Dr. Patel is the founder and CEO of KloudScript, Inc. Through KloudScript, her mission is to improve the patient experience by using technology to enable the next generation of care coordination between various industry stakeholders such as prescribers, payors, pharmaceutical manufacturers and pharmacies. She has built the largest Specialty Performance Network that uses KloudScript’s accredited processes, innovative technology platform, and a comprehensive One Pharmacy HomeTM care model to provide patients a simplified but comprehensive care experience at a community pharmacy of their choice. KloudScript has pioneered the ultimate solution for patients’ desire for local care and community pharmacies’ strategic need to participate in the fastest growing segment of pharmacy, ultimately resulting in opportunities for Payors and Pharma to embrace the retail channel through a partnership with KloudScript, Inc.

Previous to KloudScript, Inc. Dr. Patel was the Group Vice President of Business Development at Diplomat Specialty Pharmacy. She was responsible for the development of business strategy and technology solutions contributing to the growth and transformation of Diplomat. Over the last 15 years, Dr. Patel has been instrumental in helping organizations build innovative specialty care service models. Prior to Diplomat, Dr. Patel served as the Director of Pharma Relations at OptionCare, Inc. She was responsible for procurement and trade relations for OptionCare’s home infusion and specialty pharmacy divisions. Dr. Patel has held several management positions at Caremark (now CVS/Caremark) in the areas of trade relations, procurement, and technology development in addition to her tenure at Walgreens servicing patients at retail pharmacies.

Dr. Patel earned her Bachelor of Science degree in Pharmacy and her Doctor of Pharmacy degree from Midwestern University, Chicago, Illinois.

Victor Schmitt

Victor Schmitt was formerly President, Venture Management, Baxter Healthcare Corporation. He held this position since 1994 and was responsible for the creation and management of Baxter Healthcare’s interests in development-stage biotech companies. Prior to this position, he held the operating position of President, Baxter Biotech Europe. He has also served as Vice President, Business Development and Finance for Baxter Healthcare’s Blood Therapy Group. Mr. Schmitt joined Baxter Healthcare from a sixteen-year career with the American Red Cross Blood Services. At the Red Cross Blood Services, he held positions in marketing and operations. At the time of his departure, he was Vice President, Blood Services with responsibility for the organization’s national blood services program. Mr. Schmitt holds a Bachelor of Science degree from the University of Virginia and a Master of Business Administration from the University of Maryland. He has served on the board of directors of a number of development-stage life science companies.